Skip to content

ORBIMED ADVISORS LLC: NPCE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on NPCE, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,055,125 NPCE shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 1,055,125 shares
    Change vs previous 13F -450,000 shares

    0.27% of the 13F portfolio, value $14,518,520.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  2. period ended2026-06-30
    13F 1,505,125 shares
    Change vs previous 13F -591,402 shares

    0.45% of the 13F portfolio, value $23,916,436.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 2,096,527 shares
    Change vs previous 13F -309,808 shares

    0.6% of the 13F portfolio, value $27,569,330.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 2,406,335 shares
    Change vs previous 13F -207,849 shares

    0.76% of the 13F portfolio, value $37,153,812.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 2,614,184 shares
    Change vs previous 13F 0 shares

    0.65% of the 13F portfolio, value $26,952,237.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 2,614,184 shares
    Change vs previous 13F -792,151 shares

    0.73% of the 13F portfolio, value $29,122,010.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 3,406,335 shares
    Change vs previous 13F 0 shares

    1.01% of the 13F portfolio, value $41,863,857.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-12-31
    13F 3,406,335 shares
    Change vs previous 13F not available

    0.79% of the 13F portfolio, value $38,116,889.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).